Literature DB >> 10642551

Transgenic mouse model of stunned myocardium.

A M Murphy1, H Kögler, D Georgakopoulos, J L McDonough, D A Kass, J E Van Eyk, E Marbán.   

Abstract

Stunned myocardium is a syndrome of reversible contractile failure that frequently complicates coronary artery disease. Cardiac excitation is uncoupled from contraction at the level of the myofilaments. Selective proteolysis of the thin filament protein troponin I has been correlated with stunned myocardium. Here, transgenic mice expressing the major degradation product of troponin I (TnI1-193) in the heart were found to develop ventricular dilatation, diminished contractility, and reduced myofilament calcium responsiveness, recapitulating the phenotype of stunned myocardium. Proteolysis of troponin I also occurs in ischemic human cardiac muscle. Thus, troponin I proteolysis underlies the pathogenesis of a common acquired form of heart failure.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10642551     DOI: 10.1126/science.287.5452.488

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  64 in total

1.  beta(3)-adrenoceptor deficiency blocks nitric oxide-dependent inhibition of myocardial contractility.

Authors:  P Varghese; R W Harrison; R A Lofthouse; D Georgakopoulos; D E Berkowitz; J M Hare
Journal:  J Clin Invest       Date:  2000-09       Impact factor: 14.808

Review 2.  Protective responses in the ischemic myocardium.

Authors:  R S Williams; I J Benjamin
Journal:  J Clin Invest       Date:  2000-10       Impact factor: 14.808

3.  AMP-activated protein kinase phosphorylates cardiac troponin I at Ser-150 to increase myofilament calcium sensitivity and blunt PKA-dependent function.

Authors:  Benjamin R Nixon; Ariyoporn Thawornkaiwong; Janel Jin; Elizabeth A Brundage; Sean C Little; Jonathan P Davis; R John Solaro; Brandon J Biesiadecki
Journal:  J Biol Chem       Date:  2012-04-06       Impact factor: 5.157

4.  Muscle-specific RING finger 1 is a bona fide ubiquitin ligase that degrades cardiac troponin I.

Authors:  Vishram Kedar; Holly McDonough; Ranjana Arya; Hui-Hua Li; Howard A Rockman; Cam Patterson
Journal:  Proc Natl Acad Sci U S A       Date:  2004-12-15       Impact factor: 11.205

Review 5.  Structural based insights into the role of troponin in cardiac muscle pathophysiology.

Authors:  Monica X Li; Xu Wang; Brian D Sykes
Journal:  J Muscle Res Cell Motil       Date:  2005-02-09       Impact factor: 2.698

6.  Calpain-1-sensitive myofibrillar proteins of the human myocardium.

Authors:  Judit Barta; Attila Tóth; István Edes; Miklós Vaszily; Julius Gy Papp; András Varró; Zoltán Papp
Journal:  Mol Cell Biochem       Date:  2005-10       Impact factor: 3.396

7.  Uncoupling store-operated Ca2+ entry and altered Ca2+ release from sarcoplasmic reticulum through silencing of junctophilin genes.

Authors:  Yutaka Hirata; Marco Brotto; Noah Weisleder; Yi Chu; Peihui Lin; Xiaoli Zhao; Angela Thornton; Shinji Komazaki; Hiroshi Takeshima; Jianjie Ma; Zui Pan
Journal:  Biophys J       Date:  2006-03-24       Impact factor: 4.033

8.  Top-down quantitative proteomics identified phosphorylation of cardiac troponin I as a candidate biomarker for chronic heart failure.

Authors:  Jiang Zhang; Moltu J Guy; Holly S Norman; Yi-Chen Chen; Qingge Xu; Xintong Dong; Huseyin Guner; Sijian Wang; Takushi Kohmoto; Ken H Young; Richard L Moss; Ying Ge
Journal:  J Proteome Res       Date:  2011-07-28       Impact factor: 4.466

9.  Altered cross-bridge characteristics following haemodynamic overload in rabbit hearts expressing V3 myosin.

Authors:  J N Peterson; R Nassar; P A Anderson; N R Alpert
Journal:  J Physiol       Date:  2001-10-15       Impact factor: 5.182

10.  Removal of the N-terminal extension of cardiac troponin I as a functional compensation for impaired myocardial beta-adrenergic signaling.

Authors:  Han-Zhong Feng; Min Chen; Lee S Weinstein; Jian-Ping Jin
Journal:  J Biol Chem       Date:  2008-09-24       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.